New treatment regimens in chronic hepatitis C

New drugs, such as simeprevir, sofosbuvir and daclatasvir, have the advantage of once-daily dosing, fewer adverse effects and efficacy against multiple hepatitis C virus genotypes

Source: Pharmacy Europe - February 16, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Hepatic disorders Featured Articles Source Type: news